We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

By HospiMedica International staff writers
Posted on 06 Aug 2026

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. More...

Standard care relies on surgery and systemic therapy, yet tools for targeted intraperitoneal delivery and early detection of recurrence remain limited. These gaps hinder durable disease control and expose patients to repeated invasive procedures. To help address this challenge, researchers have developed an implant that delivers therapy directly within the peritoneal cavity while enabling on-treatment monitoring of tumor response.

The replenishable peritoneal implant was created by CÚRAM, the Research Ireland Centre for Medical Devices at the University of Galway, working with the University of Minnesota, the Massachusetts Institute of Technology, and the Wyss Institute. The device is designed to be placed inside the peritoneal cavity, where ovarian cancer most commonly spreads. It aims to support sustained, localized treatment while minimizing the procedural burden on patients.

The implant is made from a flexible biomaterial that conforms to internal anatomical contours. A porous membrane allows therapeutic agents to diffuse gently and evenly into surrounding tissues, while an external transcutaneous port enables clinicians to replenish the device without additional surgery. This design supports repeated delivery of living cell therapies as well as other cell- and non-cell-based treatments.

The system also functions as a sampling platform. Gentle suction through the same port can collect peritoneal fluid during treatment without requiring a separate procedure. This two-way capability could allow clinicians to monitor immune-cell activity and tumor response in real time, helping guide ongoing therapeutic decisions.

In preclinical studies, the implant remained functional for up to 70 days without implant-related complications and achieved significantly better tumor control over time than conventional treatments. The findings were published in Device. The researchers propose placing the device during initial surgery to remove as much tumor tissue as possible, allowing it to target residual disease during the following weeks and months.

The platform’s adaptable design may also support treatment of other peritoneal malignancies, including gastric, colorectal, and pancreatic cancers. The researchers envision long-term implantation for localized recurrence monitoring and early retreatment when necessary. Additional studies are planned before the technology advances to clinical trials.

“One of the most frustrating aspects of treating ovarian cancer is that we know localized delivery of therapy works better, but the tools we've had until now weren't built for the job. We designed this implant with ovarian cancer patients in mind. We wanted an implant that can deliver living cell therapies repeatedly, reliably and with real precision to the tumor site,” said Dr. Aoibhín Sheedy, a Ph.D. graduate with CÚRAM at the University of Galway and lead researcher on the project.

“This work represents a shift in how we think about treating ovarian cancer, bringing therapy directly to the disease site while simultaneously learning from the tumor microenvironment in real time, which provides important insights to guide precision care,” said Professor Melissa Gellar, professor of gynecologic oncology and associate director of clinical research at the Masonic Cancer Center at the University of Minnesota and co-lead on the research.

Related Links
CÚRAM at the University of Galway
University of Minnesota
 


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: Shutterstock

AI-Derived Heart Age Linked to Cardiovascular and Dementia-Related Mortality

Cardiovascular disease is increasingly associated with dementia-related mortality and other forms of age-related decline. Identifying people with greater long-term vulnerability before severe outcomes... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.